Download PDF
J Knee Surg 2017; 30(03): 218-222
DOI: 10.1055/s-0036-1584188
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Stacked Modalities' Thromboprophylactic Therapy for Patients Undergoing Total Knee Replacement Surgery

Limin Jiang
1   Department of the Osteoarthropathy, Yantaishan Hospital, Yantai, Shandong, China
,
Shudong Zhang
1   Department of the Osteoarthropathy, Yantaishan Hospital, Yantai, Shandong, China
,
Yuchi Zhao
1   Department of the Osteoarthropathy, Yantaishan Hospital, Yantai, Shandong, China
› Author Affiliations
Further Information

Publication History

22 October 2015

10 April 2016

Publication Date:
23 May 2016 (online)

    Permissions and Reprints

Abstract

Thromboprophylaxis is a controversial and challenging topic in joint replacement surgery. Mechanical prophylaxis in combination with the use of anticoagulants have been shown to have greater efficacy than single modalities. But the early use of anticoagulants has the potential to increases the risk of postoperative bleeding. The purpose of this study was to evaluate the thromboprophylactic effects of sequential combined method using early-mechanical compression with delayed rivaroxaban in total knee arthroplasty. A retrospective cohort study, including 369 patients receiving simultaneous combined mechanical and pharmacological thromboprophylactic modality and 385 patients receiving sequential combined modality with early-mechanical compression treatment followed by rivaroxaban 2 days later after primary total knee arthroplasty surgery was conducted. The incidence rates of proximal and distal deep vein thrombosis (DVT) on the 2nd day and the 5th week and the volume of wound drainage were compared postoperatively. On the 2nd postoperative day, the incidence rates of proximal and distal DVT in the sequential group (1.56, 4.16%) had no significant difference compared with those (1.08, 3.25%) in the simultaneous group (p = 0.569, 0.507, respectively). No difference was found in the incidence rate of proximal and distal DVT on the 5th week between groups. No pulmonary embolism occurred. The mean volume of wound drainage in the sequential group was 343 mL which was 98 mL lesser than in the simultaneous group (p < 0.001). The sequential combined method as called “stacked modalities” thromboprophylactic therapy following total knee arthroplasty was safe and effective. The use of the mechanical compression method alone during the early-postoperative 48 hours, then followed by rivaroxaban then until the 5th week had the same antithrombotic effects and reduced the postoperative wound drainage volume as compared with simultaneous combined modalities.

Keywords

total knee arthroplasty - deep vein thrombosis - intermittent pneumatic compression
 

  • References

  • 1 Jameson SS, Charman SC, Gregg PJ, Reed MR, van der Meulen JH. The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after hip replacement: a non-randomised comparison from information in the National Joint Registry. J Bone Joint Surg Br 2011; 93 (11) 1465-1470
    PubMedGoogle Scholar
  • 2 Eriksson BI, Kakkar AK, Turpie AG , et al. Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement. J Bone Joint Surg Br 2009; 91 (5) 636-644
    CrossrefPubMedGoogle Scholar
  • 3 Raskob GE, Gallus AS, Pineo GF , et al. Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials. J Bone Joint Surg Br 2012; 94 (2) 257-264
    PubMedGoogle Scholar
  • 4 Kakkos SK, Caprini JA, Geroulakos G, Nicolaides AN, Stansby GP, Reddy DJ. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. Cochrane Database Syst Rev 2008; 8 (4) CD005258
    PubMedGoogle Scholar
  • 5 Falck-Ytter Y, Francis C, Johanson NA , et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis. 9th ed, American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e326S-350s
    CrossrefPubMedGoogle Scholar
  • 6 Hill J, Treasure T ; National Clinical Guideline Centre for Acute and Chronic Conditions. Reducing the risk of venous thromboembolism in patients admitted to hospital: summary of NICE guidance. BMJ 2010; 340: c95
    CrossrefPubMedGoogle Scholar
  • 7 Francis CW. Prevention of VTE in patients having major orthopedic surgery. J Thromb Thrombolysis 2013; 35 (3) 359-367
    CrossrefPubMedGoogle Scholar
  • 8 Rawat A, Huynh TT, Peden EK, Kougias P, Lin PH. Primary prophylaxis of venous thromboembolism in surgical patients. Vasc Endovascular Surg 2008; 42 (3) 205-216
    CrossrefPubMedGoogle Scholar
  • 9 Kakkar AK, Brenner B, Dahl OE , et al; RECORD2 Investigators. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet 2008; 372 (9632) 31-39
    CrossrefPubMedGoogle Scholar
  • 10 Eriksson BI, Borris LC, Friedman RJ , et al; RECORD1 Study Group. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 2008; 358 (26) 2765-2775
    CrossrefPubMedGoogle Scholar
  • 11 Lassen MR, Ageno W, Borris LC , et al; RECORD3 Investigators. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med 2008; 358 (26) 2776-2786
    CrossrefPubMedGoogle Scholar
  • 12 Turpie AG, Lassen MR, Davidson BL , et al; RECORD4 Investigators. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet 2009; 373 (9676) 1673-1680
    CrossrefPubMedGoogle Scholar
  • 13 Chen AH, Frangos SG, Kilaru S, Sumpio BE. Intermittent pneumatic compression devices — physiological mechanisms of action. Eur J Vasc Endovasc Surg 2001; 21 (5) 383-392
    CrossrefPubMedGoogle Scholar
  • 14 Kumar S, Walker MA. The effects of intermittent pneumatic compression on the arterial and venous system of the lower limb: a review. J Tissue Viability 2002; 12 (2) 58-60 , 62–66
    PubMedGoogle Scholar
  • 15 Lurie F, Awaya DJ, Kistner RL, Eklof B. Hemodynamic effect of intermittent pneumatic compression and the position of the body. J Vasc Surg 2003; 37 (1) 137-142
    CrossrefPubMedGoogle Scholar
  • 16 Guyton DP, Khayat A, Husni EA, Schreiber H. Elevated levels of 6-keto-prostaglandin-F1a from a lower extremity during external pneumatic compression. Surg Gynecol Obstet 1988; 166 (4) 338-342
    PubMedGoogle Scholar
  • 17 Summaria L, Caprini JA, McMillan R , et al. Relationship between postsurgical fibrinolytic parameters and deep vein thrombosis in surgical patients treated with compression devices. Am Surg 1988; 54 (3) 156-160
    PubMedGoogle Scholar
  • 18 Comerota AJ, Chouhan V, Harada RN , et al. The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Ann Surg 1997; 226 (3) 306-313 , discussion 313–314
    CrossrefPubMedGoogle Scholar
  • 19 Kessler CM, Hirsch DR, Jacobs H, MacDougall R, Goldhaber SZ. Intermittent pneumatic compression in chronic venous insufficiency favorably affects fibrinolytic potential and platelet activation. Blood Coagul Fibrinolysis 1996; 7 (4) 437-446
    CrossrefPubMedGoogle Scholar
  • 20 Chin PL, Amin MS, Yang KY, Yeo SJ, Lo NN. Thromboembolic prophylaxis for total knee arthroplasty in Asian patients: a randomised controlled trial. J Orthop Surg (Hong Kong) 2009; 17 (1) 1-5
    CrossrefPubMedGoogle Scholar
  • 21 Pitto RP, Hamer H, Heiss-Dunlop W, Kuehle J. Mechanical prophylaxis of deep-vein thrombosis after total hip replacement a randomised clinical trial. J Bone Joint Surg Br 2004; 86 (5) 639-642
    CrossrefPubMedGoogle Scholar
  • 22 Stone MH, Limb D, Campbell P, Stead D, Culleton G. A comparison of intermittent calf compression and enoxaparin for thromboprophylaxis in total hip replacement. A pilot study. Int Orthop 1996; 20 (6) 367-369
    PubMedGoogle Scholar
  • 23 Warwick D, Harrison J, Glew D, Mitchelmore A, Peters TJ, Donovan J. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial. J Bone Joint Surg Am 1998; 80 (8) 1158-1166
    CrossrefPubMedGoogle Scholar
  • 24 Blanchard J, Meuwly JY, Leyvraz PF , et al. Prevention of deep-vein thrombosis after total knee replacement. Randomised comparison between a low-molecular-weight heparin (nadroparin) and mechanical prophylaxis with a foot-pump system. J Bone Joint Surg Br 1999; 81 (4) 654-659
    CrossrefPubMedGoogle Scholar
  • 25 Kakkos SK, Caprini JA, Geroulakos G, Nicolaides AN, Stansby GP, Reddy DJ. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thrombo-embolism in high-risk patients. Eur J Vasc Endovasc Surg 2009; 37 (3) 364-365
    CrossrefPubMedGoogle Scholar
  • 26 Kakkos SK, Warwick D, Nicolaides AN, Stansby GP, Tsolakis IA. Combined (mechanical and pharmacological) modalities for the prevention of venous thromboembolism in joint replacement surgery. J Bone Joint Surg Br 2012; 94 (6) 729-734
    PubMedGoogle Scholar
  • 27 Roberts VC, Cotton LT. Failure of low-dose heparin to improve efficacy of peroperative intermittent calf compression in preventing postoperative deep vein thrombosis. BMJ 1975; 3 (5981) 458-460
    CrossrefPubMedGoogle Scholar
  • 28 Warwick D. New concepts in orthopaedic thromboprophylaxis. J Bone Joint Surg Br 2004; 86 (6) 788-792
    CrossrefPubMedGoogle Scholar